Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.

Parra-Millán R, Vila-Farrés X, Ayerbe-Algaba R, Varese M, Sánchez-Encinales V, Bayó N, Pachón-Ibáñez ME, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y.

J Antimicrob Chemother. 2018 Sep 4. doi: 10.1093/jac/dky343. [Epub ahead of print]

PMID:
30188994
2.

Anti-EGF nanobodies block EGFR activation via two distinct molecular recognition mechanisms.

Guardiola S, Varese M, Sánchez-Navarro M, Vincke C, Teixido M, Garcia J, Muyldermans S, Giralt E.

Angew Chem Int Ed Engl. 2018 Aug 28. doi: 10.1002/anie.201807736. [Epub ahead of print]

PMID:
30152597
3.

d-Polyarginine Lipopeptides as Intestinal Permeation Enhancers.

Garcia J, Fernández-Blanco Á, Teixidó M, Sánchez-Navarro M, Giralt E.

ChemMedChem. 2018 Jul 31. doi: 10.1002/cmdc.201800428. [Epub ahead of print]

PMID:
30063113
4.

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Guardiola S, Prades R, Mendieta L, Brouwer AJ, Streefkerk J, Nevola L, Tarragó T, Liskamp RMJ, Giralt E.

Cell Chem Biol. 2018 Aug 16;25(8):1031-1037.e4. doi: 10.1016/j.chembiol.2018.04.013. Epub 2018 May 17.

PMID:
29779956
5.

Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides.

Arranz-Gibert P, Ciudad S, Seco J, García J, Giralt E, Teixidó M.

Sci Rep. 2018 Apr 24;8(1):6446. doi: 10.1038/s41598-018-24517-6.

6.

Bromotryptophans and their incorporation in cyclic and bicyclic privileged peptides.

García-Pindado J, Willemse T, Goss R, Maes BUW, Giralt E, Ballet S, Teixidó M.

Biopolymers. 2018 Mar 12. doi: 10.1002/bip.23112. [Epub ahead of print]

PMID:
29528113
7.

PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.

Niu Z, Samaridou E, Jaumain E, Coëne J, Ullio G, Shrestha N, Garcia J, Durán-Lobato M, Tovar S, Santander-Ortega MJ, Lozano MV, Arroyo-Jimenez MM, Ramos-Membrive R, Peñuelas I, Mabondzo A, Préat V, Teixidó M, Giralt E, Alonso MJ.

J Control Release. 2018 Apr 28;276:125-139. doi: 10.1016/j.jconrel.2018.03.004. Epub 2018 Mar 6.

PMID:
29518466
8.

Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic Approach.

McCully M, Sanchez-Navarro M, Teixido M, Giralt E.

Curr Pharm Des. 2018;24(13):1366-1376. doi: 10.2174/1381612824666171201115126.

9.

Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.

Kalafatovic D, Giralt E.

Molecules. 2017 Nov 8;22(11). pii: E1929. doi: 10.3390/molecules22111929. Review.

10.

Toward a Novel Drug To Target the EGF-EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides.

Guardiola S, Seco J, Varese M, Díaz-Lobo M, García J, Teixidó M, Nevola L, Giralt E.

Chembiochem. 2018 Jan 4;19(1):76-84. doi: 10.1002/cbic.201700519. Epub 2017 Nov 29.

PMID:
29105934
11.

Combating virulence of Gram-negative bacilli by OmpA inhibition.

Vila-Farrés X, Parra-Millán R, Sánchez-Encinales V, Varese M, Ayerbe-Algaba R, Bayó N, Guardiola S, Pachón-Ibáñez ME, Kotev M, García J, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y.

Sci Rep. 2017 Oct 31;7(1):14683. doi: 10.1038/s41598-017-14972-y.

12.

Improving gold nanorod delivery to the central nervous system by conjugation to the shuttle Angiopep-2.

Velasco-Aguirre C, Morales-Zavala F, Salas-Huenuleo E, Gallardo-Toledo E, Andonie O, Muñoz L, Rojas X, Acosta G, Sánchez-Navarro M, Giralt E, Araya E, Albericio F, Kogan MJ.

Nanomedicine (Lond). 2017 Oct;12(20):2503-2517. doi: 10.2217/nnm-2017-0181. Epub 2017 Sep 8.

PMID:
28882086
13.

Cytosolic delivery: Just passing through.

Sánchez-Navarro M, Teixidó M, Giralt E.

Nat Chem. 2017 Jul 25;9(8):727-728. doi: 10.1038/nchem.2837. No abstract available.

PMID:
28754938
14.

Jumping Hurdles: Peptides Able To Overcome Biological Barriers.

Sánchez-Navarro M, Teixidó M, Giralt E.

Acc Chem Res. 2017 Aug 15;50(8):1847-1854. doi: 10.1021/acs.accounts.7b00204. Epub 2017 Jul 17.

PMID:
28715199
15.

Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease.

Morales-Zavala F, Arriagada H, Hassan N, Velasco C, Riveros A, Álvarez AR, Minniti AN, Rojas-Silva X, Muñoz LL, Vasquez R, Rodriguez K, Sanchez-Navarro M, Giralt E, Araya E, Aldunate R, Kogan MJ.

Nanomedicine. 2017 Oct;13(7):2341-2350. doi: 10.1016/j.nano.2017.06.013. Epub 2017 Jun 30.

PMID:
28673851
16.

Blood-brain barrier peptide shuttles.

Sánchez-Navarro M, Giralt E, Teixidó M.

Curr Opin Chem Biol. 2017 Jun;38:134-140. doi: 10.1016/j.cbpa.2017.04.019. Epub 2017 May 27. Review.

PMID:
28558293
17.

Bike peptides: a ride through the membrane.

García-Pindado J, Royo S, Teixidó M, Giralt E.

J Pept Sci. 2017 Apr;23(4):294-302. doi: 10.1002/psc.2993. Epub 2017 Mar 16.

PMID:
28303616
18.

The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer.

Giralt E, Lo Re D.

Molecules. 2017 Feb 9;22(2). pii: E198. doi: 10.3390/molecules22020198. Review.

19.

The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.

Prades R, Munarriz-Cuezva E, Urigüen L, Gil-Pisa I, Gómez L, Mendieta L, Royo S, Giralt E, Tarragó T, Meana JJ.

Eur Neuropsychopharmacol. 2017 Feb;27(2):180-191. doi: 10.1016/j.euroneuro.2016.11.016. Epub 2016 Dec 14.

PMID:
27986355
20.

Measuring the Spin-Polarization Power of a Single Chiral Molecule.

Aragonès AC, Medina E, Ferrer-Huerta M, Gimeno N, Teixidó M, Palma JL, Tao N, Ugalde JM, Giralt E, Díez-Pérez I, Mujica V.

Small. 2017 Jan;13(2). doi: 10.1002/smll.201602519. Epub 2016 Oct 18.

PMID:
27753200

Supplemental Content

Loading ...
Support Center